Repro Med Systems, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 3/13/2017
Contact Info
  • 24 Carpenter Road
  • Chester, NY 10918

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Nov 30, 2016 10-Q
CIK 0000704440
Fiscal Year End 2/28
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: NY, USA
Year of Inc. 1980
Employees 65 a/o Feb 29, 2016
Company Officers/Contacts
Andrew I. Sealfon CEO
Karen Fisher CFO, IR
Company Directors
Andrew I. Sealfon Chairman
David W Anderson
Paul Mark Baker
Joseph M Manko, Jr.
Mark Pastreich
Arthur J. Radin
Brad A. Sealfon
Service Providers
Accounting/Auditing Firm
McGrail, Merkel, Quinn & Associates
Clay Avenue Professional Plaza
1173 Clay Avenue
Scranton, PA, 18510
United States
Securities Counsel
Salon Marrow Dyckman Newman & Broudy LLP
292 Madison Ave
6th Floor
New York, NY, 10017
United States
Investor Relations Firm

Not Available
Company History
  • Sponsored for OTCQX by Salon Marrow Dyckman Newman & Broudy LLP on 9/18/2015
REPR Security Details
Share Structure
Market Value1 $16,627,245 a/o Apr 28, 2017
Authorized Shares 50,000,000 a/o Feb 28, 2016
Outstanding Shares 37,746,300 a/o Oct 07, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 27,592,362 a/o Feb 28, 2015
Par Value 0.01
Shareholders of Record 1,015 a/o May 13, 2016
Short Selling Data
Short Interest 4,651 (1.95%)
Mar 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security